雷米马佐拉姆麻醉治疗一类谷氨酸酸患者的儿科患者:一个病例报告
Tomoko Tsuruno1, Hiroki Tateiwa1, Yuki Hashimoto1
1Department of Anesthesiology and Intensive Care Medicine, Kochi Medical School, Kochi, JPN.
谷氨酸酸尿症I型 (GA-1) 麻醉管理可能具有挑战性. 雷米马佐拉姆为GA-1患者提供了一个潜在的更安全的替代品,确保了成功的麻醉疗程与仔细的外科护理.
科学领域:
- 麻醉学 麻醉学
- 代谢障碍 代谢障碍 代谢障碍
- 儿科手术 儿科手术
背景情况:
- 谷氨酸酸尿症I型 (GA-1) 是一种罕见的遗传代谢障碍.
- 对GA-1患者的麻醉管理没有充分记录.
- 在GA-1中线粒体功能障碍使麻醉选择复杂化.
更多相关视频
08:49Assessing Changes in Volatile General Anesthetic Sensitivity of Mice after Local or Systemic Pharmacological Intervention
Published on: October 16, 2013
06:59Characterization of Metabolic Status in Nonhuman Primates with the Intravenous Glucose Tolerance Test
Published on: November 13, 2016
相关概念视频
Parenteral Anesthetics: Overview
Inhalational Anesthetics: Overview
Antiepileptic Drugs: Glutamate Antagonists
Prevention of Further Absorption of Poison
Acid Halides to Ketones: Gilman Reagent
As shown below, the mechanism proceeds in two steps. First, one of the alkyl groups of the reagent acts as a nucleophile and attacks the acyl carbon of the acid chloride to form a tetrahedral intermediate. This is followed by the reformation of the carbon–oxygen...
Antiepileptic Drugs: GABAergic Pathway Potentiators
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
